Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02278536 · ClinicalTrials.gov registry record
Multiple Gestation Study
A clinical trial of Trisomy 21 and Trisomy 18, sponsored by Natera.
- Completed
- Registry status
- 354
- Enrollment target
- 8
- Study locations
NCT02278536 is a study of Trisomy 21 and Trisomy 18 that has completed, run by Natera. The registered enrollment target is 354 participants, below the 796-participant average among 5 other Trisomy 21 trials with a reported enrollment target (56% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT02278536, a study of Trisomy 21 and Trisomy 18, has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 354 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objectives of the clinical study are to demonstrate the accuracy of our new NATUS diagnostic method to determine the genetic health of the developing fetuses in a multiple gestation pregnancy from a maternal blood sample. The long term goal of this study will be the development of a method of minimally invasive prenatal diagnosis that has a higher sensitivity and lower false positive rate in the intended population (e.g. multiple gestation pregnancies) than any currently available screening tests. This will result in fewer unnecessary amniocenteses and CVS procedures, which are associated with a risk of miscarriage.
Conditions Studied
Study Locations (8)
California
- Natera, Inc. - San Carlos
- San Diego Perinatal Center - San Diego
Texas
- Office of Dr. Robert Carpenter - Houston
- Houston Perinatal Associates - Houston
New York
- Carnegie Hill Imaging for Women - New York
North Carolina
- Lyndhurst Clinical Research - Winston-Salem
Other
- Bangalore Fetal Medicine Centre - Bangalore
Selangor
- Fetal Medicine & Gynaecology Centre - Petaling Jaya
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02278536
The ClinicalTrials.gov registry entry for NCT02278536 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 796-participant average among 5 other Trisomy 21 trials with a reported enrollment target (56% lower). The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Trisomy 21 appearing as the primary indexed condition, and to 0 interventions.
NCT02278536 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, Texas, New York.
Frequently Asked Questions
What is clinical trial NCT02278536 about?
NCT02278536 is a clinical study titled "Multiple Gestation Study". The objectives of the clinical study are to demonstrate the accuracy of our new NATUS diagnostic method to determine the genetic health of the developing fetuses in a multiple gestation pregnancy from a maternal blood sample. The long term goal of this study will be the development of a method of mi...
What is the current status of trial NCT02278536?
This trial is currently completed. The enrollment target is 354 participants. The study started on 2013-03. Estimated completion is 2019-03.
What conditions does trial NCT02278536 study?
This clinical trial studies the following conditions: Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities.
Who is sponsoring clinical trial NCT02278536?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02278536 being conducted?
This trial has 8 study locations across California, New York, North Carolina, Texas, Selangor. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trisomy 21
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Human Trisome Project
RECRUITING
-
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
RECRUITING · NA
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
COMPLETED
-
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
COMPLETED
-
Down Syndrome Metabolic Health Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.